In a report released yesterday, Bill Selesky from Argus Research maintained a Hold rating on Air Products and Chemicals (APD – Research ...

Corteva (NYSE:CTVA) on Monday was upgraded to Buy from a previous investment rating of Hold by analysts at Argus Research.

Fintel reports that on March 31, 2025, Argus Research upgraded their outlook for Corteva (NYSE:CTVA) from Hold to Buy.

Argus Research analyst Marie Ferguson maintained a Hold rating on Centerpoint Energy (CNP – Research Report) yesterday. The company’s shares ...

Fintel reports that on April 4, 2025, Argus Research downgraded their outlook for Biogen (BIT:1BIIB) from Buy to Hold. As of April 2, 2025, the average one-year price target for Biogen is €185. ...

Fintel reports that on April 4, 2025, Argus Research downgraded their outlook for Biogen (WBAG:BIIB) from Buy to Hold. There are 1,721 funds or institutions reporting positions in Biogen.

NEW YORK, April 3, 2025 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on Golden Matrix Group, Inc. (NasdaqCM: GMGI) Click Here ...

Argus Research downgraded Lululemon Athletica (NASDAQ:LULU) to "hold" from "buy," citing concerns over an aging product line, U.S. tariffs, and intensifying competition from rivals like Nike (NYSE:NKE ...

Corteva (NYSE:CTVA) on Monday was upgraded to Buy from a previous investment rating of Hold by analysts at Argus Research. They said the maker of farm chemicals and seeds offers improved demand ...